ArticleMikrochimica acta2025
Copper single-atom-based flexible aptamer biochip for simultaneous monitoring of bladder cancer-related bacteria.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gold Nanoparticles in Bladder Cancer Applications: A Paradigm Shift from Diagnostic Tools to Integrated Theranostic Platforms.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
R apid and accurate detection of pathogenic bacteria is crucial for disease diagnosis in clinical practice. The infection of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) is closely related to the development and complications of patients with bladder cancer. In this study, an aptamer biochip for E. coli and S. aureus simultaneous detection was developed based on copper single atom material (Cu-SAC) and gold nanoparticles (AuNPs) via high-resolution electrohydrodynamic (EHD) printing technology. The main strategy was based on the specific recognition of aptamer and the signal amplification of AuNPs/Cu-SAC. Following aptamer immobilization, the electrochemical signal gradually decreased. Using this proposed electrochemical aptamer biochip, E. coli and S. aureus can be quantified at a linearity range of 10-1.0 × 10
Indexed as
Identifiers
40830418What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.